Activation of porcine endothelium in response to xenogeneic serum causes thrombosis independently of platelet activation

Xenotransplantation

Volumn 12, Issue 2, 2005, Pages 110-120

  Galbusera, Miriam ^a   Buelli, Simona ^a   Gastoldi, Sara ^a   Macconi, Daniela ^a   Angioletti, Stefania ^a   Testa, Cristian ^a   Remuzzi, Giuseppe ^a,b   Morigi, Marina ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

Adhesive proteins; Complement; Oxidants; Platelets; Shear stress

Indexed keywords

ADHESIVE AGENT; ANTIOXIDANT; COMPLEMENT COMPONENT C3B RECEPTOR; DIMETHYLTHIOUREA; HYDROGEN PEROXIDE; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; VITRONECTIN RECEPTOR; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GRAFT REJECTION; IMMUNE RESPONSE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; SHEAR STRESS; SWINE; THROMBOCYTE ACTIVATION; THROMBOSIS; XENOGRAFT;

ANIMALS; ANTIOXIDANTS; CELL ADHESION MOLECULES; CELLS, CULTURED; ENDOTHELIUM; HUMANS; HYDROGEN PEROXIDE; PLATELET ACTIVATION; PROTEIN BINDING; REACTIVE OXYGEN SPECIES; SERUM; SWINE; THROMBOSIS;

EID: 14644429642     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2005.00203.x     Document Type: Article

References (40)

1. BACH FH, ROBSON SC, WINKLER H et al. Barriers to xenotransplantation. Nat Med 1995; 1: 869.
2. PARKER W, SAADI S, LIN SS et al. Transplantation of discordant xenografts: a challenge revisited. Immunol Today 1996; 17: 373.
3. SAMSTEIN B, PLATT JL. Physiologic and immunologic hurdles to xenotransplantation. J Am Soc Nephrol 2001; 12: 182.
4. DANIELS LJ, PLATT JL. Hyperacute xenograft rejection as an immunologic barrier to xenotransplantation. Kidney Int 1997; 51: S28.
5. LEVENTHAL JR, DALMASSO AP, CROMWELL JW et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55: 857.
6. PRUITT SK, KIRK AD, BOLLINGER RR et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994; 57: 363.
7. PLATT JL, VERCELLOTTI GM, LINDMAN BJ et al. Release of heparan sulfate from endothelial cells: implications for pathogenesis of hyperacute rejection. J Exp Med 1990; 171: 1363.
8. IHRCKE NS, WRENSHALL LE, LINDMAN BJ, PLATT JL. Role of heparan sulfate in immune system-blood vessel interactions. Immunol Today 1993; 14: 500.
9. SAADI S, PLATT JL. Transient perturbation of endothelial integrity induced by antibodies and complement. J Exp Med 1995; 181: 21.
10. LOWENHAUPT R, NATHAN P. Platelet accumulation observed by electron microscopy in the early phase of renal allotransplant rejection. Nature 1968; 220: 822.
11. SAADI S, HOLZKNECHT RA, PATTE CP, STERN DM, PLATT JL. Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med 1995; 182: 1807.
12. MORIGI M, ZOJA C, COLLEONI S et al. Xenogeneic serum promotes leukocyte-endothelium interaction under flow through two temporally distinct pathways: role of complement and nuclear factor-kB. J Am Soc Nephrol 1999; 10: 2197.
13. MURPHY HS, SHAYMAN JA, TILL GO et al. Superoxide responses of endothelial cells to C5a and TNF-a: divergent signal transduction pathways. Am J Physiol 1992; 263: L51.
14. FOREMAN KE, VAPORCIYAN AA, BONISH BK et al. C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 1994; 94: 1147.
15. REMUZZI G, GALBUSERA M, SALVADORI M et al. Bilateral nephrectomy stopped disease progression in plasma-resistant hemolytic uremic syndrome with neurological signs and coma. Kidney Int 1996; 49: 282.
16. RUGGERI ZM. Perspectives series: cell adhesion in vascular biology, von Willebrand Factor. J Clin Invest 1997; 99: 559.
17. 3 in vascular biology. Thromb Haemost 1998; 80: 726.
18. FRENETTE PS, JOHNSON RC, HYNES RO, WAGNER DD. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci U S A 1995; 92: 7450.
19. MORIGI M, GALBUSERA M, BINDA E et al. Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress. Blood 2001; 98: 1828.
20. CANDINAS D, LESNIKOSKI BA, HANCOCK WW et al. Inhibition of platelet integrin GpIIbIIIa prolongs survival of discordant cardiac xenografts. Transplantation 1996; 62: 1.
21. CHEN G, WEI Q, WANG X-M et al. TMVA, a novel GPIb-binding protein, significantly prevents platelet microthrombi formation and prolongs discordant cardiac xenograft survival. Xenotransplantation 2004; 11: 203.
22. COUGHLAN AF, BERNDT MC, DUNLOP LC, HANCOCK WW. In vivo studies of P-selectin and platelet activating factor during endotoxemia, accelerated allograft rejection, and discordant xenograft rejection. Transplant Proc 1993; 25: 2930.
23. MAKOWKA L, CHAPMAN FA, CRAMER DV et al. Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts. Transplantation 1990; 50: 359.
24. KOYAMADA N, MIYATAKE T, CANDINAS D et al. Apyrase administration prolongs discordant xenograft survival. Transplantation 1996; 62: 1739.
25. PHILLIPS MD, MOAKE JL, NOLASCO L, TURNER N. Aurin tricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets. Blood 1988; 72: 1898.
26. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956.
27. 2 through a PKC-dependent pathway. J Am Soc Nephrol 2002; 13: 1179.
28. 2 in cultured endothelial cells. Arch Biochem Biophys 1993; 302: 348.
29. KOOY NW, ROYALL JA, ISCHIROPOULOS H, BECKMAN JS. Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic Biol Med 1994; 16: 149.
30. BUSTOS M, SAADI S, PLATT JL. Platelet-mediated activation of endothelial cells: implications for the pathogenesis of transplant rejection. Transplantation 2001; 72: 509.
31. Xu H, ARNAUD F, TADAKI DK et al. Human platelets activate porcine endothelial cells through a CD154-dependent pathway. Transplantation 2001; 72: 1858.
32. MASSBERG S, ENDERS G, LEIDERER R et al. Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin. Blood 1998; 92: 507.
33. PADILLA A, MOAKE JL, BERNARDO A et al. P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. Blood 2004; 103: 2150.
34. SCHULTE AM, ESCH J 2nd, CRUZ MA et al. Activation of human platelets by the membrane-expressed Al domain of von Willebrand factor. Blood 1997; 90: 4425.
35. PARETI FI, MAZZUCATO M, BOTTINI E, MANNUCCI PM. Interaction of porcine von Willebrand factor with the platelet glycoproteins Ib and IIb/IIIa complex. Br J Haematol 1992; 82: 81.
36. HATTORI R, HAMILTON KK, MCEVER RP, SIMS PJ. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem 1989; 264: 9053.
37. VISCHER UM, JORNOT L, WOLLHEIM CB, THELER J-M. Reactive oxygen intermediates induce regulated secretion of von Willebrand Factor from cultured human vascular endothelial cells. Blood 1995; 85: 3164.
38. PATEL KD, ZIMMERMAN GA, PRESCOTT SM, MCEVER RP, MCINTYRE TM. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol 1991; 112: 749.
39. AKGUR FM, BROWN MF, ZIBARI GB et al. Role of superoxide in hemorrhagic shock-induced P-selectin expression. Am J Physiol Heart Circ Physiol 2000; 279: H791.
40. PEIRE MA, PUIG-PARELLADA P. Oxygen-free radicals and nitric oxide are involved in the thrombus growth produced by iontophoresis of ADP. Pharmacol Res 1998; 38: 353.